Dedicated to Discovery. Committed to Care.

Mission Possible: The Dana-Farber Campaign to Conquer Cancer

Funding Priorities

Campaign funding to fuel Institute's top priorities

Dana-Farber's $1 billion capital campaign is the catalyst that will enable the Institute to change the cancer landscape and, ultimately, conquer the disease. To make its mission possible, Dana-Farber seeks investments in four critical areas:

Research and Care: $450 million

doctor and patient

The campaign will enable the Institute to build upon its hallmark: a unique 50-50 balance between cancer research and patient care. Like no other, Dana-Farber has invested equally in laboratory-based discoveries and patient- and family-centered care, pursuing each with the same determination and vigor. The result has been a potent convergence of the two, enabling the creation of a robust pipeline for drug discovery and the rapid translation of laboratory breakthroughs into effective new treatments that extend and save lives.

Technology: $100 million

lab technician

Achieving the next round of cancer breakthroughs demands powerful new tools that enable investigators to penetrate the complexities of cancer cells. A number of new and emerging technologies hold tremendous potential to accelerate the pace and progress of cancer research. The campaign will fuel Dana-Farber's investment in five core technology platforms – chemical biology, computational biology, genomics, imaging, and proteomics – that are essential to the rapid development of targeted new treatments.

The Yawkey Center for Cancer Care: $150 million

Yawkey Center for Cancer Care

The most visible funding priority of the campaign is the construction of a new, state-of-the-art clinical facility. To accommodate its dramatic rise in patient volumes, Dana-Farber broke ground in the spring of 2007 on its 275,000-square-foot, 13-story Yawkey Center for Cancer Care. The facility will house 100 exam rooms, 150 infusion chairs, and the Clinical Research Center, which will accommodate more patients undergoing clinical trials.

The Jimmy Fund and Unrestricted Funds: $300 million

The Jimmy Fund provides flexible funding that benefits the entire Institute and supports its most pressing needs, now and in the future. Gifts without restriction are critical to the Institute's successes and are crucial to the campaign because they provide senior Institute leaders with funds to use where and when they are needed most. As its patient care, research, education, and outreach initiatives continue to grow, so too does Dana-Farber's need for this steady, adaptable funding.

For more information

Contact: Julia Parrillo, Campaign Director
Phone: (617) 632-6573
E-mail: julia_parrillo@dfci.harvard.edu

Related Story

Mission Possible Campaign

doctor and patient

Boldly recognizing that the opportunity to conquer cancer is within reach, Dana-Farber has launched a $1 billion capital campaign – the largest and most ambitious fundraising campaign in its history. Be a part of it. read more